A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA array

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2433-2439

  Anderson, K M ^a   Alrefai, W A ^a   Bonomi, P A ^a   Anderson, C A ^b   Dudeja, P ^c   Harris, J E ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

5 lipoxygenase; Bronchiolar carcinoma; Inhibitor; MK 886

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; COMPLEMENTARY DNA; DNA; LIPOXYGENASE INHIBITOR; MESSENGER RNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANTINEOPLASTIC AGENTS; ARACHIDONATE 5-LIPOXYGENASE; DNA, COMPLEMENTARY; HUMANS; INDOLES; LIPOXYGENASE INHIBITORS; LUNG NEOPLASMS;

EID: 0033853784     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78: 539-542, 1996.
2. Zakeri Z, Busch W, Tenniswood M, Lockshin RA Cell Death: programmed, apoptosis, necrosis or other? Cell Death Diff 2: 87-96, 1995.
3. Anderson KM, Seed T, Meng J, Ou D et al: Five-lipoxygenase inhibitors reduce PANC-I survival: The mode of cell death and synergism of MK 886 with gamma linolenic acid. Anticancer Res 18: 791-800, 1998.
4. Clark P: Developmental cell death: morphologic diversity and multiple mechanisms. Anat Embryol 181: 195-213, 1990.
5. Martin DS, Stoffi RL, Colofiore JR: Perspective: The chemotherapeutic relevance of apoptosis and a proposed biochemical cascade for chemotherapeutically induced apoptosis. Cancer Invest 15: 372-381, 1997.
6. Anderson KM, Seed T, Vos M et al: 5-Lipoxygernase inhibitors reduce PC-3 cell proliferation and initiate non-necrotic cell death. The Prostate 37: 161-173, 1998.
7. Avis IM, Jett M, Boyle T et al: Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. Clin Invest 97: 806-813, 1996.
8. Ford-Hutchinson AW, Cresser M, Young RN: 5-Lipoxygenase. Ann Rev Biochem 61: 383-417, 1994.
9. Ou D, Bonomi P, Harris JE et al: The mode of cell death in a lung cancer cell line cultured with an inhibitor of 5-lipoxygenase or the free radical spin trap, NTBN, FASEB J 12: abst # 783, 1998.
10. Anderson KM, Alrefrai WA, Bonomi P et al: Altered oncogene, tumor suppressor and cell-cycle gene expression in Panc-1 cells cultured with the pleiotrophic 5 lipoxygenase inhibitor, MK 886, assessed with a gene chip. Anticancer Res 19: 3873-3888, 1999.
11. Anderson KM, Alrefrai WA, Bonomi P et al: ms in preparation and personal communication from our co-author, Dr. J Mulshine,
12. DeRisi Jj, Penland L, Brown PO et al: Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nature Gen 14: 457-460, 1996.
13. DeRisi J, Iyer VR, Brown PO: Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278: 680-686, 1997.
14. Zhang W, Chenchik A, Chen S et al: Molecular profiling of human gliomas by cDNA expression array. J Gene Med 1: 57-59 (1997).
15. Iyer VR, Eisen MB, Ross DT et al: The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87, 1998.
16. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Nat Acad Sci US 95: 14863-14868, 1998
17. Ermolaeva O, Rastogi M, Pruitt KD et al: Data management and analysis for gene expression arrays. Nature Gen 20: 19-23, 1998.
18. Klevecz B. Mathcad turns micro-arrays into live images. The Scientist, March 29, pg. 24, 1999.